[4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum

C75H62BN5OPt — CID 177090217

IUPAC[4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum
SMILES[2H]c1c([2H])c([2H])c2c(c1[2H])n(-c1cccc(Oc3nc(N4B5c6ccccc6-c6ccccc6N5c5ccccc54)cc(C([2H])([2H])[2H])c3-c3ccccc3)c1)c(=[Pt])n2-c1c(-c2ccc(-c3ccccc3)cc2)cccc1-c1cc(C(C)(C)C)cc(C(C)(C)C)c1
InChIInChI=1S/C75H62BN5O.Pt/c1-50-44-70(81-69-39-21-20-38-68(69)80-65-35-17-15-31-63(65)62-30-14-16-34-64(62)76(80)81)77-73(71(50)54-26-12-9-13-27-54)82-59-29-22-28-58(48-59)78-49-79(67-37-19-18-36-66(67)78)72-60(53-42-40-52(41-43-53)51-24-10-8-11-25-51)32-23-33-61(72)55-45-56(74(2,3)4)47-57(46-55)75(5,6)7;/h8-48H,1-7H3;/i1D3,18D,19D,36D,37D;
InChIKeyWWDLREZSKGYIPN-JCVVPFLNSA-N
MW1262.29 g/mol
LogP18.92
Rot. Bonds10

About [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum

[4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum (PubChem CID 177090217) has the molecular formula C75H62BN5OPt and a molecular weight of 1262.29 g/mol. Its IUPAC name is [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum.

Molecular Properties

Compound Name[4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum
PubChem CID177090217
Molecular FormulaC75H62BN5OPt
Molecular Weight1262.29 g/mol
Exact Mass1261.51
IUPAC Name[4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum
SMILES[2H]c1c([2H])c([2H])c2c(c1[2H])n(-c1cccc(Oc3nc(N4B5c6ccccc6-c6ccccc6N5c5ccccc54)cc(C([2H])([2H])[2H])c3-c3ccccc3)c1)c(=[Pt])n2-c1c(-c2ccc(-c3ccccc3)cc2)cccc1-c1cc(C(C)(C)C)cc(C(C)(C)C)c1
InChIInChI=1S/C75H62BN5O.Pt/c1-50-44-70(81-69-39-21-20-38-68(69)80-65-35-17-15-31-63(65)62-30-14-16-34-64(62)76(80)81)77-73(71(50)54-26-12-9-13-27-54)82-59-29-22-28-58(48-59)78-49-79(67-37-19-18-36-66(67)78)72-60(53-42-40-52(41-43-53)51-24-10-8-11-25-51)32-23-33-61(72)55-45-56(74(2,3)4)47-57(46-55)75(5,6)7;/h8-48H,1-7H3;/i1D3,18D,19D,36D,37D;
InChIKeyWWDLREZSKGYIPN-JCVVPFLNSA-N
XLogP18.92
TPSA38.46 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds10
Heavy Atoms83
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001262.29
LogP ≤ 518.92
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum?
The IUPAC name of [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum (CID 177090217) is [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum.
What is the SMILES notation for [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum?
The canonical SMILES for [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum is [2H]c1c([2H])c([2H])c2c(c1[2H])n(-c1cccc(Oc3nc(N4B5c6ccccc6-c6ccccc6N5c5ccccc54)cc(C([2H])([2H])[2H])c3-c3ccccc3)c1)c(=[Pt])n2-c1c(-c2ccc(-c3ccccc3)cc2)cccc1-c1cc(C(C)(C)C)cc(C(C)(C)C)c1.
What is the InChIKey of [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum?
The InChIKey is WWDLREZSKGYIPN-JCVVPFLNSA-N. The full InChI is InChI=1S/C75H62BN5O.Pt/c1-50-44-70(81-69-39-21-20-38-68(69)80-65-35-17-15-31-63(65)62-30-14-16-34-64(62)76(80)81)77-73(71(50)54-26-12-9-13-27-54)82-59-29-22-28-58(48-59)78-49-79(67-37-19-18-36-66(67)78)72-60(53-42-40-52(41-43-53)51-24-10-8-11-25-51)32-23-33-61(72)55-45-56(74(2,3)4)47-57(46-55)75(5,6)7;/h8-48H,1-7H3;/i1D3,18D,19D,36D,37D;.
What are the key properties of [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum?
[4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum has a molecular weight of 1262.29 g/mol, XLogP of 18.92, 10 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [4,5,6,7-tetradeuterio-1-[3-[[6-(14,21-diaza-1-borapentacyclo[12.7.0.02,7.08,13.015,20]henicosa-2,4,6,8,10,12,15,17,19-nonaen-21-yl)-3-phenyl-4-(trideuteriomethyl)-2-pyridinyl]oxy]phenyl]-3-[2-(3,5-ditert-butylphenyl)-6-(4-phenylphenyl)phenyl]benzimidazol-2-ylidene]platinum is sourced from PubChem (CID 177090217), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).